RSI Closes Sale of Principal Asset and Pursues New

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
23
RSI Closes Sale of Principal Asset and Pursues New Business Acquisition

VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- RSI International Systems Inc . (TSX-V: RSY ) (“RSI” or the “Company”) is pleased to report that it has closed the sale (the “Transaction”) of its RoomKeyPMS business to NSight Inc., (“NSight” or the “Purchaser”) as originally announced  September 7, , 2018 and updated January 9, 2019. Initial gross proceeds from the sale, which are for all of the Company’s business assets, are approximately $6 million. After providing for adjustments to the Purchaser net proceeds from the Transaction are approximately $5.6 million. The Company intends to use the funds to acquire a new business.

Mr. David Keys, Chairman of RSI and a representative for the Ernest W. Moody Revocable Trust, which holds 44.4% of RSI’s outstanding shares commented, “With this transaction closed and funds in hand, we are moving as quickly as possible to conclude a suitable acquisition. In the interim, we are minimizing our costs and expect to fund our expenses as much as possible from the interest generated on our cash.”

Shareholders’ Approval of the Transaction At the RSI shareholder meeting held on Feb 5, 2019, 64.7% of the Company’s outstanding shares were voted in person or by proxy. 100% of the votes cast in respect of the Transaction were in favour.

For further details on the Transaction, please see the Company’s news releases dated September 7, 2018 and January 9, 2019, as well as the Company’s Information Circular dated January 9, 2019 and available at www.sedar.com

Proceeds from the Transaction As per the Definitive Agreement announced by the Company January 9, 2019, the Company sold its RoomKeyPMS business to NSight Inc. on an arm’s length basis, for gross proceeds of US$4.6 million. This amount was adjusted to a Canadian dollar amount of approximately C$6 million by averaging the posted Bank of Canada rate for the average of the seven business prior to September 7, 2018 and the average of the seven business days prior to February 5, 2019, to arrive at an exchange rate of 1.3127 US to Canadian dollars. As NSight is not assuming any of RSI’s liabilities except where necessary to run the business going forward, the assumption of any such liabilities was deducted from the gross proceeds. The gross proceeds were adjusted to account for the timing of certain receivables, payables, deferred revenue, prepaid costs and other items that are assumed by NSight. Totaling these adjustments and subtracting them from the gross purchase price, leaves a net proceeds figure of approximately C$5.6 million. In addition, by undertaking the Transaction, the Company incurred additional costs, including approximately C$247 thousand for change of control payments to departing senior managers.

Appointment of New Senior Management and Board Member In conjunction with the sale of the RoomKeyPMS business, all of the Company’s management have resigned to take roles with NSight. Accordingly, the Company also announces that it has appointed Adam Ho, as President & Chief Executive Officer, (“CEO”) replacing Tim Major. Mr. Ho has been a member of the Company’s Board of Directors since August 2016 and was instrumental in completing the sale of the Company’s business.

The Company also announces the appointment of Sam Wong as Chief Financial Officer, (“CFO”) replacing Giovanni Susin. Mr. Wong is currently the Chief Financial Officer of various junior mining public companies that are listed on the TSX Venture. He was also previously the Chief Financial Officer of Goldgroup Mining Inc, where he significantly decreased the cost of and levels of debt through various cost cutting and restructuring initiatives. Mr. Wong is a Chartered Professional Accountant and articled at Deloitte LLP in Vancouver, BC.

The Company also reports that at its February 5, 2019 shareholder meeting, shareholders re-elected David Keys and Adam Ho as Directors and elected Anthony Balic to the Company’s Board for the first time. Mr. Balic replaces Mr. Fai Ambrose Heng Chan, who did not stand for re-election.  Mr. Balic is a Director of Montan Mining Corp. and has worked with Canadian and U.S. publicly listed companies for the past 13 years. He is currently the CFO of Goldgroup Mining Inc., Captiva Verde Land Corp., Omni Commerce Corp. and Montan Mining Corp. Prior to his involvement with public companies, Mr. Balic was a Senior Manager at Deloitte LLP in Vancouver, where he specialized in assurance and advisory services for clients in various industries.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About NSight With the acquisition of the RoomKeyPMS business, NSight continues to aggressively identify and acquire leading technology platforms that are core to hotel’s operations.  This strategy provides middle market hotels more efficient technology solutions while creating exceptional value for NSight shareholders.

About RSI  RSI International Systems Inc. has recently sold its only business asset, RoomKeyPMS. The Company is now seeking to use the net sale proceeds to acquire a new business.

Cautionary Note Regarding Forward Looking Statements This news release contains forward-looking statements. Any statements that are not strictly historical fact are considered "forward-looking statements." Forward-looking statements cannot be guaranteed and involve assumptions and are subject to a variety of risks and uncertainties which could cause actual events or results to materially differ from those reflected in the forward-looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and not place undue reliance upon forward-looking statements. Any forward-looking statements made herein are made as of the date hereof, and the Company assumes no obligation and disclaims any intention to revise or update any forward-looking information and statements except as required by applicable laws.

For more information, please contact:

RSI Systems International Inc. Adam Ho, CEO & Director 604-329-1009 adamho@shaw.ca

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading